Number of Shares
0
Previous 200 100.0%
Holding current value
$0
Previous $10.6 Million 2.95%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025

BUY
$40.91 - $56.0 $8,181 - $11,200
200 New
200 $10.9 Million
Q3 2025

Oct 03, 2025

SELL
$40.91 - $56.0 $8,181 - $11,200
-200 Closed
0 $10.9 Million
Q1 2025

May 20, 2025

BUY
$43.04 - $58.51 $8,608 - $11,702
200 New
200 $8.66 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ransom Advisory, LTD Portfolio

Follow Ransom Advisory, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ransom Advisory, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ransom Advisory, LTD with notifications on news.